This report studies the Contrast Injector market, Contrast delivery is most effective and efficient using a medical device called a “power injector” that can be programmed to deliver specific amounts of contrast medium. This “power injector” is the Contrast Medium Injector.
Due to the COVID-19 pandemic, the global Contrast Medium Injector market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Contrast Medium Injector market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Contrast Medium Injector landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Analysts have envisaged the North Americas to dominate this market because of the augmented use of contrast medium injectors in medical imaging and radiology procedures. While this region presently dominates the market for contrast medium injectors, analysts estimate the APAC region to show the highest growth during the forecast period as a result of its large population base.
This report focuses on Contrast Medium Injector volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Contrast Medium Injector market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Contrast Medium Injector Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Single-head Contrast Injector
Dual-head Contrast Injector
Segment by Application
CT
MRI
Angiography
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Bayer
Bracco
Nemoto
Guerbet
Ulrich medical
MEDTRON
APOLLO RT
SinoMDT
Anke High-Tech